Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China
· Delayed Price · Currency is CNY 9.69
0.00 (0.00%)
At close: Mar 9, 2026
SHA:603707 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 15,656 | 21,439 | 24,169 | 29,075 | 52,058 | 32,706 | Upgrade
|
| Market Cap Growth | -30.64% | -11.29% | -16.87% | -44.15% | 59.17% | 10.12% | Upgrade
|
| Enterprise Value | 15,377 | 21,794 | 25,024 | 30,396 | 54,143 | 34,595 | Upgrade
|
| Last Close Price | 9.69 | 13.15 | 14.74 | 17.58 | 31.32 | 20.07 | Upgrade
|
| PE Ratio | 24.12 | 25.95 | - | 26.65 | 49.14 | 40.57 | Upgrade
|
| Forward PE | 15.38 | 17.95 | 19.44 | 19.56 | 38.80 | 33.70 | Upgrade
|
| PS Ratio | 4.16 | 5.46 | 6.15 | 7.83 | 14.12 | 11.22 | Upgrade
|
| PB Ratio | 2.32 | 3.30 | 4.17 | 4.72 | 9.64 | 8.73 | Upgrade
|
| P/TBV Ratio | 2.49 | 3.56 | 4.39 | 4.91 | 10.13 | 9.35 | Upgrade
|
| P/FCF Ratio | 17.53 | 21.56 | 20.14 | 231.92 | 214.34 | - | Upgrade
|
| P/OCF Ratio | 11.63 | 14.28 | 14.93 | 48.83 | 76.15 | - | Upgrade
|
| EV/Sales Ratio | 4.09 | 5.56 | 6.37 | 8.19 | 14.69 | 11.87 | Upgrade
|
| EV/EBITDA Ratio | 19.48 | 19.19 | - | 26.18 | 40.86 | 34.17 | Upgrade
|
| EV/EBIT Ratio | 25.59 | 22.63 | - | 29.76 | 43.96 | 37.28 | Upgrade
|
| EV/FCF Ratio | 17.22 | 21.92 | 20.85 | 242.46 | 222.93 | - | Upgrade
|
| Debt / Equity Ratio | 0.36 | 0.32 | 0.45 | 0.48 | 0.38 | 0.87 | Upgrade
|
| Debt / EBITDA Ratio | 3.07 | 1.83 | - | 2.56 | 1.55 | 3.22 | Upgrade
|
| Debt / FCF Ratio | 2.72 | 2.09 | 2.17 | 23.70 | 8.45 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | 0 | 0.12 | 0.26 | 0.21 | 0.51 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.35 | 0.00 | -3.96 | 1.36 | 0.86 | 1.90 | Upgrade
|
| Net Debt / FCF Ratio | -0.31 | 0.00 | 0.59 | 12.61 | 4.67 | -2.24 | Upgrade
|
| Asset Turnover | 0.38 | 0.41 | 0.40 | 0.41 | 0.46 | 0.46 | Upgrade
|
| Inventory Turnover | 0.59 | 0.54 | 0.67 | 0.34 | 0.34 | 0.32 | Upgrade
|
| Quick Ratio | 1.30 | 1.59 | 0.94 | 0.96 | 0.88 | 0.80 | Upgrade
|
| Current Ratio | 2.46 | 3.41 | 2.35 | 3.07 | 3.06 | 2.41 | Upgrade
|
| Return on Equity (ROE) | 9.98% | 13.45% | -3.17% | 18.78% | 23.26% | 23.61% | Upgrade
|
| Return on Assets (ROA) | 3.81% | 6.33% | -2.13% | 7.00% | 9.66% | 9.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.93% | 12.35% | -4.66% | 13.11% | 17.84% | 16.81% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.30% | 12.90% | -5.20% | 14.00% | 20.70% | 18.90% | Upgrade
|
| Earnings Yield | 4.15% | 3.85% | -0.78% | 3.75% | 2.04% | 2.46% | Upgrade
|
| FCF Yield | 5.71% | 4.64% | 4.96% | 0.43% | 0.47% | -2.63% | Upgrade
|
| Dividend Yield | 1.03% | 0.76% | 0.68% | 0.65% | 0.37% | 0.44% | Upgrade
|
| Payout Ratio | 31.80% | 25.81% | - | 20.78% | 18.10% | 32.40% | Upgrade
|
| Buyback Yield / Dilution | -1.33% | -4.66% | 3.03% | -2.98% | 0.43% | -0.94% | Upgrade
|
| Total Shareholder Return | -0.30% | -3.90% | 3.71% | -2.32% | 0.80% | -0.50% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.